The microbial identification market is expected to reach USD 3.00 billion by 2022 from USD 2.18 billion in 2017, growing at a CAGR of 6.6%.
- Advertising -
The microbial identification market is dominated by North America, followed by Europe in 2017. Asia is estimated to grow at the fastest rate which can be attributed to developing healthcare infrastructure, rising burden of infectious diseases, and increasing initiatives to promote the use of novel technologies for microbial identification.
Access report at www.reportsnreports.com/reports/29…sts-to-2019.html
Factors driving the growth of this market include the increasing prevalence of infectious diseases, technological advancements in microbial identification, increasing food safety concerns, and government initiatives to promote use of microbial identification.
- Advertising -
On the other hand, the high cost of automated microbial identification systems is expected to limit market growth in the coming years. Complex regulatory frameworks that delay the approval of new microbial diagnostic tests are also expected to challenge market growth to a certain extent.
The consumables used for microbial identification are anticipated to grow at the highest CAGR during the forecast. The need of consumables in large numbers as compared to instruments is the primary factor responsible for this positive market growth.
The microbial identification market by application, is categorized into diagnostic applications (human disease diagnosis and animal disease diagnosis), food testing, beverage testing, cosmetics and personal care products testing, pharmaceutical applications, environmental applications, and other applications.
Access this Report @ www.reportsnreports.com/contacts/r…aspx?name=292942
The key players in the microbial identification market include Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), bioMérieux S.A.
(France), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Bruker Corporation (US), Shimadzu Corporation (Japan), VWR Corporation (US), Eurofins Scientific S.E.
(Luxembourg), GTCR, LLC. (US), QIAGEN N.V. (Netherlands), Liofilchem s.r.l.
(Italy), IEH Laboratories & Consulting Group (US), Alcami Corporation (US), Biolog, Inc. (US), Abellon CleanEnergy Limited (India), Alpha Analytical, Inc.
(US), NeoGenomics, Inc. (US), Trivitron Healthcare (India), Molzym GmbH & Co. KG (Germany), Dynatec Labs (US), Altogen Labs (US), STERIS plc (UK), and Wickham Laboratories Ltd.
Target Audience for this Report:
- Academic and research institutes
- Hospitals, clinics, and laboratories
- Clinical research organizations (CROs)
- Microbial identification service providers
- Culture collection repositories
- Diagnostic associations
- Venture capitalists
- Life sciences instrumentation and reagent companies
- Business research and consulting firms
- Government bodies
- Microbial identification database and software providers
- Venture capitalists
Access report at www.reportsnreports.com/contacts/d…aspx?name=292942
“The proteomics-based methods segment is estimated to grow at a rapid rate during the analysis period”
By method, the microbial identification market is segmented into phenotypic, genotypic, and proteomics-based methods. The proteomics-based methods segment is the fastest growing segment of the global microbial identification market on the basis of method.
The rising demand for proteomics-based methods on account of greater levels of sensitivity, accuracy, and specificity is driving the demand for this segment.
Key point from Table of content
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Microbial Identification Market, By Product and Service
7 Microbial Identification Market, By Method
8 Microbial Identification Market, By Application
9 Microbial Identification Market, By End User
10 Microbial Identification Market, By Region
11 Competitive Landscape
12 Company Profiles
Access Report @ www.reportsnreports.com/purchase.aspx?name=292942